SK280222B6 - Farmaceutický alebo veterinárny prostriedok - Google Patents

Farmaceutický alebo veterinárny prostriedok Download PDF

Info

Publication number
SK280222B6
SK280222B6 SK495-96A SK49596A SK280222B6 SK 280222 B6 SK280222 B6 SK 280222B6 SK 49596 A SK49596 A SK 49596A SK 280222 B6 SK280222 B6 SK 280222B6
Authority
SK
Slovakia
Prior art keywords
weight
pharmaceutical
veterinary composition
mineral oil
alcohol
Prior art date
Application number
SK495-96A
Other languages
English (en)
Slovak (sk)
Other versions
SK49596A3 (en
Inventor
Harvey L. Zimmerman
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26303736&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK280222(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB939321876A external-priority patent/GB9321876D0/en
Priority claimed from GB939322288A external-priority patent/GB9322288D0/en
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of SK49596A3 publication Critical patent/SK49596A3/sk
Publication of SK280222B6 publication Critical patent/SK280222B6/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK495-96A 1993-10-22 1994-10-20 Farmaceutický alebo veterinárny prostriedok SK280222B6 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939321876A GB9321876D0 (en) 1993-10-22 1993-10-22 Novel composition
GB939322288A GB9322288D0 (en) 1993-10-29 1993-10-29 Novel composition
PCT/US1994/012026 WO1995010999A1 (fr) 1993-10-22 1994-10-20 Nouvelle composition

Publications (2)

Publication Number Publication Date
SK49596A3 SK49596A3 (en) 1997-02-05
SK280222B6 true SK280222B6 (sk) 1999-10-08

Family

ID=26303736

Family Applications (1)

Application Number Title Priority Date Filing Date
SK495-96A SK280222B6 (sk) 1993-10-22 1994-10-20 Farmaceutický alebo veterinárny prostriedok

Country Status (28)

Country Link
US (1) US6025389A (fr)
EP (1) EP0727979B1 (fr)
JP (1) JPH09506865A (fr)
KR (1) KR100374462B1 (fr)
CN (1) CN1102410C (fr)
AP (1) AP608A (fr)
AT (1) ATE202467T1 (fr)
AU (1) AU692486B2 (fr)
BG (1) BG62912B1 (fr)
BR (1) BR9407840A (fr)
CA (1) CA2174658C (fr)
CZ (1) CZ292223B6 (fr)
DE (1) DE69427589T2 (fr)
DK (1) DK0727979T3 (fr)
ES (1) ES2157996T3 (fr)
FI (1) FI116931B (fr)
GR (1) GR3036591T3 (fr)
HK (1) HK1012284A1 (fr)
HU (1) HU221853B1 (fr)
NO (1) NO313446B1 (fr)
NZ (1) NZ275282A (fr)
OA (1) OA10361A (fr)
PL (1) PL177592B1 (fr)
PT (1) PT727979E (fr)
RO (1) RO112987B1 (fr)
SK (1) SK280222B6 (fr)
UA (1) UA39896C2 (fr)
WO (1) WO1995010999A1 (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4910145A1 (es) * 1996-10-01 2000-04-24 Smithkline Beecham Corp Uso
HUP9904308A3 (en) * 1996-10-01 2002-06-28 Smithkline Beecham Plc Use of mupirocin for manufacture of a medicament for the treatment of bacterial infections associated with colonisation by pathogenic organisms at the nasopharynx
EP1033969A1 (fr) * 1997-09-11 2000-09-13 Smithkline Beecham Plc Compositions adaptees pour un sejour prolonge dans le rhino-pharynx
IL123143A (en) * 1998-02-02 2001-08-26 Agis Ind 1983 Ltd Pharmaceutical compositions containing mupirocin
GB9808470D0 (en) 1998-04-22 1998-06-17 Smithkline Beecham Plc Novel process and apparatus
IL137363A (en) * 2000-07-18 2005-12-18 Agis Ind 1983 Ltd Pharmaceutical compositions containing mupirocin
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
EP1619947A4 (fr) * 2003-05-01 2006-05-31 Replidyne Inc Compositions antibacteriennes et procedes associes
US20050123576A1 (en) * 2003-12-03 2005-06-09 Ilana Lavon Mupirocin compositions for topical use, an improved process of making same and methods of using same
WO2008007182A2 (fr) * 2006-07-07 2008-01-17 Glenmark Pharmaceuticals Limited Compositions pharmaceutiques topiques de mupirocine ou sels ou esters de qualité pharmaceutique de ces composés
EP2552440B1 (fr) 2010-03-30 2018-10-10 Helperby Therapeutics Limited Nouveau traitement combiné et utilisation associée
GB201013207D0 (en) 2010-08-05 2010-09-22 Helperby Therapeutics Ltd Novel combination
WO2012017215A1 (fr) 2010-08-05 2012-02-09 Helperby Therapeutics Limited Combinaison d'une pyrroquinoléine et d'un agent antimicrobien de type bêta-lactame, de mupirocine ou de chlorhexidine
GB201015079D0 (en) 2010-09-10 2010-10-27 Helperby Therapeutics Ltd Novel use
CN103249402A (zh) 2010-10-08 2013-08-14 赫尔普百治疗有限公司 新组合物
DK2704704T3 (en) 2011-05-03 2019-01-14 Dupont Nutrition Biosci Aps PROBIOTIC BACTERIES FOR TOPICAL TREATMENT OF SKIN DISORDERS
GB201107755D0 (en) 2011-05-10 2011-06-22 Helperby Therapeutics Ltd Novel compounds
CN102335122B (zh) * 2011-06-21 2013-04-17 北京协和药厂 一种莫匹罗星软膏及其制备方法
DE102012215511A1 (de) 2012-08-31 2014-06-12 Schülke & Mayr GmbH Verfahren zur Herstellung einer Bispyridiniumalkan enthaltenden halbfesten Zubereitung
GB201305277D0 (en) 2013-03-22 2013-05-01 Helperby Therapeutics Ltd Novel combination and use
GB201307989D0 (en) 2013-05-02 2013-06-12 Helperby Therapeutics Ltd Novel combinations and use
US10292389B2 (en) * 2013-12-17 2019-05-21 Dr. Reddy's Laboratories, S.A. Pediculicidal composition
GB201401617D0 (en) 2014-01-30 2014-03-19 Helperby Therapeutics Ltd Novel combination and use
US10335454B2 (en) 2014-12-18 2019-07-02 Helperby Therapeutics Limited Combination and use
WO2016133471A1 (fr) 2015-02-20 2016-08-25 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A. Ş. Composition topique contenant de la mupirocine et du dexpanthénol
GB201518969D0 (en) 2015-10-27 2015-12-09 Helperby Therapeutics Ltd Triple combination
AU2017253935B2 (en) 2016-04-19 2021-07-29 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of gram negative species to treat atopic dermatitis
US10293005B2 (en) 2016-04-19 2019-05-21 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of gram negative species to treat atopic dermatitis
GB201610869D0 (en) 2016-06-22 2016-08-03 Helperby Therapeutics Ltd Combination
GB201620095D0 (en) 2016-11-28 2017-01-11 Terali Innov Sas And Univ De Strasbourg And Inserm (Inst Nat De La Sante Et De La Rech Medicale) And Novel use
GB201709193D0 (en) 2017-06-09 2017-07-26 Helperby Therapeutics Ltd Combination
WO2019141957A1 (fr) 2018-01-19 2019-07-25 Cado Biotechnology Ivs Dérivés d'hydroxy pyrazole n-pyrimidinyle et utilisations associées
GB2588721A (en) 2018-05-11 2021-05-05 Forte Subsidiary Inc Compositions for the treatment of skin conditions
WO2020081109A1 (fr) * 2018-10-17 2020-04-23 Glenmark Pharmaceuticals Inc., Usa Crème à base de mupirocine en flacon pompe
IL271778A (en) 2019-12-31 2021-06-30 Ichilov Tech Ltd Methods for treating atopic dermatitis
US20210299019A1 (en) * 2020-03-31 2021-09-30 Chemistryrx Methods for treating hyperpigmentation and compositions for same
AU2022251858A1 (en) 2021-03-30 2023-09-07 International N&H Denmark Aps Compositions and methods for treating and preventing gastrointestinal inflammation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3758686A (en) * 1971-12-07 1973-09-11 American Cyanamid Co Method of using steroid acetonides
US3934013A (en) * 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition
NZ200918A (en) * 1981-07-02 1985-07-31 Gist Brocades Nv Stable fatty oil-in-water emulsion cream for topical application
GB8530796D0 (en) * 1985-12-13 1986-01-22 Beecham Group Plc Pharmaceutical composition
IE59628B1 (en) * 1986-06-26 1994-03-09 Beecham Group Plc Treatment of fungal infections
US4847068A (en) * 1987-08-06 1989-07-11 Johnson & Johnson Consumer Products, Inc. Skin care compositions

Also Published As

Publication number Publication date
AU8084794A (en) 1995-05-08
EP0727979A1 (fr) 1996-08-28
AP608A (en) 1997-08-28
BG100501A (bg) 1996-12-31
CZ112096A3 (en) 1996-07-17
CA2174658C (fr) 2000-12-19
GR3036591T3 (en) 2001-12-31
FI961720A (fi) 1996-04-19
OA10361A (en) 2001-11-21
BR9407840A (pt) 1997-05-13
NZ275282A (en) 1996-10-28
WO1995010999A1 (fr) 1995-04-27
UA39896C2 (uk) 2001-07-16
NO961588D0 (no) 1996-04-19
FI961720A0 (fi) 1996-04-19
CN1102410C (zh) 2003-03-05
PL314038A1 (en) 1996-08-05
AP9600798A0 (en) 1996-04-30
HK1012284A1 (en) 1999-07-30
HUT74510A (en) 1997-01-28
CZ292223B6 (cs) 2003-08-13
AU692486B2 (en) 1998-06-11
DK0727979T3 (da) 2001-10-01
RO112987B1 (ro) 1998-03-30
ES2157996T3 (es) 2001-09-01
NO961588L (no) 1996-04-19
PT727979E (pt) 2001-11-30
KR100374462B1 (ko) 2003-06-09
US6025389A (en) 2000-02-15
NO313446B1 (no) 2002-10-07
ATE202467T1 (de) 2001-07-15
EP0727979B1 (fr) 2001-06-27
FI116931B (fi) 2006-04-13
CN1135715A (zh) 1996-11-13
EP0727979A4 (fr) 1996-11-27
JPH09506865A (ja) 1997-07-08
BG62912B1 (bg) 2000-11-30
SK49596A3 (en) 1997-02-05
CA2174658A1 (fr) 1995-04-27
DE69427589T2 (de) 2002-04-25
HU9601030D0 (en) 1996-06-28
PL177592B1 (pl) 1999-12-31
HU221853B1 (hu) 2003-02-28
DE69427589D1 (de) 2001-08-02

Similar Documents

Publication Publication Date Title
SK280222B6 (sk) Farmaceutický alebo veterinárny prostriedok
US4879287A (en) Pharmaceutical composition
EP1174133B1 (fr) Composition pharmaceutiques contenant de mupirocine amorphe
EP0410348A1 (fr) Composition de spironolactone à usage topique
EP0727996A1 (fr) Formulations a base de fenbendazole
CA1238276A (fr) Creme de dipropionate de betamethasone
IL96903A (en) Topical pharmaceutical compositions comprising 1 alpha, 25-dihydroxychole-calciferol.
EP0445540B1 (fr) Préparation antimycotique contenant de l'imidazole pour application externe
RU2148998C1 (ru) Фармацевтическая или ветеринарная композиция (варианты) и способ получения композиции
KR900000086A (ko) 목적화합물의 약학적 조성과 그 제조방법
CZ282830B6 (cs) Léčivá mast bez dráždivého účinku na kůži a způsob její přípravy

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20121020